Form 8-K - Current report:
SEC Accession No. 0001823239-25-000059
Filing Date
2025-03-20
Accepted
2025-03-20 16:34:12
Documents
13
Period of Report
2025-03-20
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K mrvi-20250320.htm   iXBRL 8-K 34391
  Complete submission text file 0001823239-25-000059.txt   162516

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrvi-20250320.xsd EX-101.SCH 1782
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrvi-20250320_lab.xml EX-101.LAB 22548
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrvi-20250320_pre.xml EX-101.PRE 13046
15 EXTRACTED XBRL INSTANCE DOCUMENT mrvi-20250320_htm.xml XML 2833
Mailing Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121 (858) 546-0004
MARAVAI LIFESCIENCES HOLDINGS, INC. (Filer) CIK: 0001823239 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39725 | Film No.: 25756976
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)